首页> Haematologica> FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/ chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.

FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/ chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.

导出 OA

翻译打印收藏纠错

第一作者： Pierre,Peterlin

第一单位： Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes. pierre.peterlin@chu-nantes.fr.

作者： Pierre,Peterlin ^[1] ; Joëlle,Gaschet ^[2] ; Pascal,Turlure ^[3] ; Marie-Pierre,Gourin ^[3] ; Pierre-Yves,Dumas ^[4] ; Sylvain,Thepot ^[5] ; Ana,Berceanu ^[6] ; Sophie,Park ^[7] ; Marie-Anne,Hospital ^[8] ; Thomas,Cluzeau ^[9] ; Jose-Miguel,Torregrosa-Diaz ^[10] ; Louis,Drevon ^[11] ; Rosa,Sapena ^[12] ; Fatiha,Chermat ^[12] ; Lionel,Ades ^[11] ; Sophie,Dimicoli-Salazar ^[4] ; Maxime,Jullien ^[13] ; Pierre,Fenaux ^[12] ; Patrice,Chevallier ^[13]

作者单位： Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes. pierre.peterlin@chu-nantes.fr. ^[1] CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes. ^[2] Clinical Hematology, Limoges University Hospital, Limoges. ^[3] Clinical Hematology, Bordeaux University Hospital Haut-Lévêque, Pessac. ^[4] Clinical Hematology, Angers University Hospital, Angers. ^[5] Clinical Hematology, Besançon University Hospital, Besançon. ^[6] Clinical Hematology, Grenoble University Hospital, Grenoble. ^[7] Clinical Hematology, Institut Paoli Calmettes, Marseille. ^[8] Clinical Hematology, Nice University Hospital, Nice. ^[9] Clinical Hematology, Poitiers University Hospital, Poitiers. ^[10] Clinical Hematology, Saint Louis Hospital, Paris. ^[11] Groupe Francophone des Myélodysplasies, Paris. ^[12] Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université - Angers University, Nantes. ^[13]

DOI 10.3324/haematol.2024.286025

PMID 39568426

发布时间 2025-04-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Haematologica

2025年110卷4期

980-984页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/ chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.

Haematologica

相似文献

Haematologica

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/ chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.

Haematologica

相似文献

Haematologica

相关期刊

检索历史清除